نتایج جستجو برای: ageusia
تعداد نتایج: 250 فیلتر نتایج به سال:
Sweet dysgeusia, a rare taste disorder, may be encountered in severe anti-acetylcholine receptor antibody (AChRAb)-myasthenia gravis (MG). A 42 year-old man reported progressive loss of sweet taste evolving for almost 10 weeks, revealing an AChRAb-positive MG with thymoma. Improvement of sweet perception paralleled reduction of the MG composite score during the 15 months follow up period, with ...
Taste disorders are distressing for patients. They can also pose a serious threat to the health of older and more vulnerable patients, who can become malnourished through a loss of taste or changes in taste perception. Despite the profound impact of taste changes on health, the literature on their diagnosis, pathogenesis and treatment is sparse. Taste changes, including the experience of unexpl...
Unilateral taste loss is usually observed on the side contralateral to a thalamic infarction, despite gustatory function being represented bilaterally. We report a rare case of bilateral taste loss in a patient with an acute left unilateral thalamic infarction, with unilateral left insular hypometabolism demonstrated by statistical parametric map analysis of PET images. Our observations suggest...
Smell and taste alterations are very common in patients with COVID 19, even when we an asymptomatic phase of the disease, it is reported that up to 80 90% present anosmia ageusia as a cardinal symptom disease. In this manuscript will mention mode action Sars-cov-2 virus at level nasal buccal fossae, taking into account cellular result this, based on current evidence, remembering still unknown. ...
Background and Objectives: Taste sensation has a significant evolutionary, nutritional protective role in human beings. Changes the perception of taste can significantly affect overall quality life an individual. A proportion patients with changes such as ageusia (complete loss taste), hypogeusia (diminished sensation), dysgeusia (altered/distorted including phantoms like metallic/bitter taste)...
The data and regulatory considerations leading to the U.S. Food and Drug Administration (FDA) January 30, 2012 approval of Erivedge (vismodegib) capsules for the treatment of patients with recurrent, locally advanced, or metastatic basal cell carcinoma (BCC) are described. The FDA's approval decision was based primarily on the results observed in a single-arm, parallel cohort, international tri...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید